Effluxing ABC transporters in human corneal epithelium

Journal of Pharmaceutical Sciences

Volumn 99, Issue 2, 2010, Pages 1087-1098

  Vellonen, Kati Sisko ^a,b   Mannermaa, Eliisa ^b   Turner, Helen ^c   Häkli, Marika ^a   Wolosin, J Mario ^d   Tervo, Timo ^a   Honkakoski, Paavo ^b   Urtti, Arto ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c NewYork Presbyterian Hospital   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

ABC transporters; Cell culture; Cell model; Corneal epithelium; Efflux pumps; HCE; Multidrug resistance transporters; Multidrug resistance associated proteins; P glycoprotein; Primary cells

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; MULTIDRUG RESISTANCE PROTEIN 6;

ARTICLE; BASAL CELL; CELL CULTURE; CELL IMMORTALIZATION; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA LIMBUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 74049100137     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21878     Document Type: Article

References (66)

1. Maurice DM, Mishima S. 1984. Ocular pharmacokinetics. In: Sears ML, editor. Pharmacology of the eye. Berlin: Springer-Verlag. pp. 19-116.
2. Huang HS, Schoenwald RD, Lach JL. 1983. Corneal penetration behavior of beta-blocking agents II: Assessment of barrier contributions. J Pharm Sci 72:1272-1279.
3. Järvinen K, Järvinen T, Urtti A. 1995. Ocular absorption following topical delivery. Adv Drug Deliv Rev 16:3-19.
4. Toropainen E, Hornof M, Kaarniranta K, Johansson P, Urtti A. 2007. Corneal epithelium as a platform for secretion of transgene products after transfection with liposomal gene eyedrops. J Gene Med 9:208-216.
5. Suhonen P, Jarvinen T, Rytkonen P, Peura P, Urtti A. 1991. Improved corneal pilocarpine permeability with O,O'-(1,4-xylylene) bispilocarpic acid ester double prodrugs. Pharm Res 8:1539-1542.
6. Ahmed I, Gokhale RD, Shah MV, Patton TF. 1987. Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea. J Pharm Sci 76:583-586.
7. Chien DS, Sasaki H, Bundgaard H, Buur A, Lee VH. 1991. Role of enzymatic lability in the corneal and conjunctival penetration of timolol ester prodrugs in the pigmented rabbit. Pharm Res 8:728-733.
8. Urtti A, Pipkin JD, Rork G, Sendo T, Finne U, Repta AJ. 1990. Controlled drug delivery devices for experimental ocular studies with timolol 2. Ocular and systemic absorption in rabbits. Int J Pharm 61: 241-249.
9. Yu XQ, Xue CC, Wang G, Zhou SF. 2007. Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs. Curr Drug Metab 8:787-802.
10. Kennedy BG, Mangini NJ. 2002. P-glycoprotein expression in human retinal pigment epithelium. Mol Vis 8:422-430.
11. Dey S, Patel J, Anand BS, Jain-Vakkalagadda B, Kaliki P, Pal D, Ganapathy V, Mitra AK. 2003. Molecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell lines. Invest Ophthalmol Vis Sci 44:2909-2918.
12. Becker U, Ehrhardt C, Daum N, Baldes C, Schaefer UF, Ruprecht KW, Kim KJ, Lehr CM. 2007. Expression of ABC-transporters in human corneal tissue and the transformed cell line, HCE-T. J Ocul Pharmacol Ther 23:172-181.
13. Zhang T, Xiang CD, Gale D, Carreiro S, Wu EY, Zhang EY. 2008. Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: Implications for ocular drug disposition. Drug Metab Dispos 36:1300-1307.
14. Toropainen E, Ranta VP, Talvitie A, Suhonen P, Urtti A. 2001. Culture model of human corneal epithelium for prediction of ocular drug absorption. Invest Ophthalmol Vis Sci 42:2942-2948.
15. Toropainen E, Ranta VP, Vellonen KS, Palmgren J, Talvitie A, Laavola M, Suhonen P, Hamalainen KM, Auriola S, Urtti A. 2003. Paracellular and passive transcellular permeability in immortalized human corneal epithelial cell culture model. Eur J Pharm Sci 20:99-106.
16. Korjamo T, Honkakoski P, Toppinen MR, Niva S, Reinisalo M, Palmgren JJ, Monkkonen J. 2005. Absorption properties and P-glycoprotein activity of modified Caco-2 cell lines. Eur J Pharm Sci 26:266-279.
17. Chen G, Duran GE, Steger KA, Lacayo NJ, Jaffrezou JP, Dumontet C, Sikic BI. 1997. Multidrugresistant human sarcoma cells with a mutant Pglycoprotein, altered phenotype, and resistance to cyclosporins. J Biol Chem 272:5974-5982.
18. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG. 1992. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654.
19. Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJ, Juijn JA, Baas F, Borst P. 1997. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistanceassociated protein gene (MRP1), in human cancer cell lines. Cancer Res 57:3537-3547.
20. Kool M, van der Linden M, de Haas M, Scheffer GL, de Vree JM, Smith AJ, Jansen G, Peters GJ, Ponne N, Scheper RJ, Elferink RP, Baas F, Borst P. 1999. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci USA 96:6914-6919.
21. Adachi M, Sampath J, Lan LB, Sun D, Hargrove P, Flatley R, Tatum A, Edwards MZ, Wezeman M, Matherly L, Drake R, Schuetz J. 2002. Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing. J Biol Chem 277:38998-39004.
22. McAleer MA, Breen MA, White NL, Matthews N. 1999. pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells. J Biol Chem 274:23541-23548.
23. Ilias A, Urban Z, Seidl TL, Le Saux O, Sinko E, Boyd CD, Sarkadi B, Varadi A. 2002. Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J Biol Chem 277:16860-16867.
24. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD. 1998. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95:15665-15670.
25. Turner HC, Bernstein A, Candia OA. 2002. Presence of CFTR in the conjunctival epithelium. Curr Eye Res 24:182-187.
26. Turner HC, Alvarez LJ, Candia OA, Bernstein AM. 2003. Characterization of serotonergic receptors in rabbit, porcine and human conjunctivae. Curr Eye Res 27:205-215.
27. Oen H, Cheng P, Turner HC, Alvarez LJ, Candia OA. 2006. Identification and localization of aquaporin 5 in the mammalian conjunctival epithelium. Exp Eye Res 83:995-998.
28. Eneroth A, Astrom E, Hoogstraate J, Schrenk D, Conrad S, Kauffmann HM, Gjellan K. 2001. Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for Pglycoprotein interaction. Eur J Pharm Sci 12:205-214.
29. Vellonen KS, Honkakoski P, Urtti A. 2004. Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity. Eur J Pharm Sci 23:181-188.
30. Essodaigui M, Broxterman HJ, Garnier-Suillerot A. 1998. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Biochemistry 37:2243-2250.
31. Prime-Chapman HM, Fearn RA, Cooper AE, Moore V, Hirst BH. 2004. Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells. J Pharmacol Exp Ther 311:476-484.
32. Breeuwer P, Drocourt JL, Bunschoten N, Zwietering MH, Rombouts FM, Abee T. 1995. Characterization of uptake and hydrolysis of fluorescein diacetate and carboxyfluorescein diacetate by intracellular esterases in Saccharomyces cerevisiae, which result in accumulation of fluorescent product. Appl Environ Microbiol 61:1614-1619.
33. Chandra P, Zhang P, Brouwer KL. 2005. Shortterm regulation of multidrug resistance-associated protein 3 in rat and human hepatocytes. Am J Physiol Gastrointest Liver Physiol 288:G1252-G1258.
34. Pratt S, Chen V, Perry WI III, Starling JJ, Dantzig AH. 2006. Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport. Eur J Pharm Sci 27:524-532.
35. Zamek-Gliszczynski MJ, Xiong H, Patel NJ, Turncliff RZ, Pollack GM, Brouwer KL. 2003. Pharmacokinetics of 5 (and 6)-carboxy-2′,7′- dichlorofluorescein and its diacetate promoiety in the liver. J Pharmacol Exp Ther 304:801-809.
36. Haimeur A, Conseil G, Deeley RG, Cole SP. 2004. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: Biology, substrate specificity and regulation. Curr Drug Metab 5:21-53.
37. Matsson P, Pedersen JM, Norinder U, Bergstrom CA, Artursson P. 2009. Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs. Pharm Res [Epub ahead of print, published online: May 07, 2009].
38. Mannermaa E, Vellonen KS, Urtti A. 2006. Drug transport in corneal epithelium and blood-retina barrier: Emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev 58:1136-1163.
39. Bakos E, Homolya L. 2007. Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1). Pflugers Arch 453:621-641.
40. Terashi K, Oka M, Soda H, Fukuda M, Kawabata S, Nakatomi K, Shiozawa K, Nakamura T, Tsukamoto K, Noguchi Y, Suenaga M, Tei C, Kohno S. 2000. Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRPoverexpressing human leukemia cells. Antimicrob Agents Chemother 44:1697-1700.
41. Klokouzas A, Barrand MA, Hladky SB. 2001. Effects of clotrimazole on transport mediated by multidrug resistance associated protein 1 (MRP1) in human erythrocytes and tumour cells. Eur J Biochem 268:6569-6577.
42. Leier I, Hummel-Eisenbeiss J, Cui Y, Keppler D. 2000. ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2. Kidney Int 57:1636-1642.
43. Yamasaki K, Kawasaki S, Young RD, Fukuoka H, Tanioka H, Nakatsukasa M, Quantock AJ, Kinoshita S. 2009. Genomic aberrations and cellular heterogeneity in SV40-immortalized human corneal epithelial cells. Invest Ophthalmol Vis Sci 50: 604-613.
44. Bush JA, Li G. 2002. Cancer chemoresistance: The relationship between p53 and multidrug transporters. Int J Cancer 98:323-330.
45. Jedlitschky G, Burchell B, Keppler D. 2000. The multidrug resistance protein 5 functions as an ATPdependent export pump for cyclic nucleotides. J Biol Chem 275:30069-30074.
46. Wielinga PR, van der Heijden I, Reid G, Beijnen JH, Wijnholds J, Borst P. 2003. Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J Biol Chem 278: 17664-17671.
47. Ritter CA, Jedlitschky G, Meyer zu Schwabedissen H, Grube M, Kock K, Kroemer HK. 2005. Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5). Drug Metab Rev 37:253-278.
48. Borst P, de Wolf C, van de Wetering K. 2007. Multidrug resistance-associated proteins 3, 4 and 5. Pflugers Arch 453:661-673.
49. Pratt S, Shepard RL, Kandasamy RA, Johnston PA, Perry W III, Dantzig AH. 2005. The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. Mol Cancer Ther 4:855-863.
50. Poothullil AM, Colby KA. 2006. Topical medical therapies for ocular surface tumors. Semin Ophthalmol 21:161-169.
51. Nies AT, Jedlitschky G, Konig J, Herold-Mende C, Steiner HH, Schmitt HP, Keppler D. 2004. Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 129:349-360.
52. Leslie EM, Deeley RG, Cole SP. 2005. Multidrug resistance proteins: Role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol 204:216-237.
53. Wijnholds J, Mol CA, van Deemter L, de Haas M, Scheffer GL, Baas F, Beijnen JH, Scheper RJ, Hatse S, De Clercq E, Balzarini J, Borst P. 2000. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci USA 97:7476-7481.
54. Kawazu K, Yamada K, Nakamura M, Ota A. 1999. Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin. Invest Ophthalmol Vis Sci 40:1738-1744.
55. Dey S, Gunda S, Mitra AK. 2004. Pharmacokinetics of erythromycin in rabbit corneas after single-dose infusion: Role of P-glycoprotein as a barrier to in vivo ocular drug absorption. J Pharmacol Exp Ther 311:246-255.
56. Beck K, Hayashi K, Nishiguchi B, Le Saux O, Hayashi M, Boyd CD. 2003. The distribution of Abcc6 in normal mouse tissues suggests multiple functions for this ABC transporter. J Histochem Cytochem 51:887-902.
57. Karla PK, Pal D, Mitra AK. 2007. Molecular evidence and functional expression of multidrug resistance associated protein (MRP) in rabbit corneal epithelial cells. Exp Eye Res 84:53-60.
58. Watanabe K, Nishida K, Yamato M, Umemoto T, Sumide T, Yamamoto K, Maeda N, Watanabe H, Okano T, Tano Y. 2004. Human limbal epithelium contains side population cells expressing the ATPbinding cassette transporter ABCG2. FEBS Lett 565:6-10.
59. Chen Z, de Paiva CS, Luo L, Kretzer FL, Pflugfelder SC, Li DQ. 2004. Characterization of putative stem cell phenotype in human limbal epithelia. Stem Cells 22:355-366.
60. Wolosin JM, Budak MT, Akinci MA. 2004. Ocular surface epithelial and stem cell development. Int J Dev Biol 48:981-991.
61. de Paiva CS, Chen Z, Corrales RM, Pflugfelder SC, Li DQ. 2005. ABCG2 transporter identifies a population of clonogenic human limbal epithelial cells. Stem Cells 23:63-73.
62. Budak MT, Alpdogan OS, Zhou M, Lavker RM, Akinci MA, Wolosin JM. 2005. Ocular surface epithelia contain ABCG2-dependent side population cells exhibiting features associated with stem cells. J Cell Sci 118:1715-1724.
63. Chang CY, Green CR, McGhee CN, Sherwin T. 2008. Acute wound healing in the human central corneal epithelium appears to be independent of limbal stem cell influence. Invest Ophthalmol Vis Sci 49:5279-5286.
64. Merino G, Alvarez AI, Pulido MM, Molina AJ, Schinkel AH, Prieto JG. 2006. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion. Drug Metab Dispos 34:690-695.
65. Ozvegy C, Litman T, Szakacs G, Nagy Z, Bates S, Varadi A, Sarkadi B. 2001. Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. Biochem Biophys Res Commun 285:111-117.
66. Pavek P, Merino G, Wagenaar E, Bolscher E, Novotna M, Jonker JW, Schinkel AH. 2005. Human breast cancer resistance protein: Interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b) pyridine, and transport of cimetidine. J Pharmacol Exp Ther 312:144-152.